Thank you Gwaihir for the most relevant post on this forum in a long time. The reaction to your post is to say the least astonishing! Defending this company in any way shape or form is incomprehensible! Everything that you have enunciated is on the money and trying to make excuses for a this Board/Management is unfathomable. Compliance to the law is not an option for any ASX listed company - it is mandatory. Sometimes examples have to be made for the greater good. Unfortunately herding cats is problematic.
Timely, accurate and relevant communication (to all shareholders) is not something that we should have to debate and argue about - it is simply a prerequisite in meeting any companies Fiduciary Duty. This fundamental duty has been an issue with RXL and it is time they were held to account.
What is so hard about keeping shareholders informed. Even if disclosure is an issue words can be communicated that reassure shareholders without compromising confidential discussions.
So in answer to your question "does anyone think it's past time to "Take Affirmative Action (TAA)"?" my response is affirmative.
- Forums
- ASX - By Stock
- RXL
- Fiduciary Duty - Trust, Incompetence & Negligence
Fiduciary Duty - Trust, Incompetence & Negligence, page-34
Featured News
Add RXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.5¢ |
Change
-0.015(8.82%) |
Mkt cap ! $61.58M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 14.5¢ | $118.1K | 777.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 157697 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 88369 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 177697 | 0.150 |
10 | 538618 | 0.145 |
18 | 716250 | 0.140 |
5 | 145322 | 0.135 |
10 | 300724 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 88369 | 3 |
0.160 | 144999 | 5 |
0.165 | 100000 | 1 |
0.170 | 338000 | 4 |
0.180 | 174883 | 5 |
Last trade - 11.38am 13/11/2024 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online